Skip to main content
logo
Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
84.20
+1.00 (1.20%)
Aug 24, 2026, 4:25 PM CET

Oncoinvent ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
28.0728.078.15.796.2811.08
Revenue Growth
40.37%246.40%39.95%-7.85%-43.31%6.80%
Gross Profit
28.0728.078.15.796.2810.19
Operating Income
-158.33-158.33-141.02-147.43-110.61-80.83
Net Income
-155.07-155.07-140.2-143.62-106.28-80.29
Earnings Per Share
-125.13-125.13-561.04-738.62-548.04-404.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
177.6177.6133.6730.1196.02292.03
Total Debt
3.553.557.4512.1712.03-
Net Cash (Debt)
174.05174.05126.2217.92183.99292.03
Net Cash Growth
151.63%37.90%604.25%-90.26%-37.00%157.76%
Net Cash Per Share
140.45140.45505.0792.17948.731469.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-129.87-129.87-87.94-138.11-89.19-
Capital Expenditures
-0.12-0.12-1.8-26.83-3.98-
Free Cash Flow
-129.99-129.99-89.75-164.94-93.17-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%91.92%
Operating Margin
-564.07%-564.07%-1740.31%-2546.20%-1760.48%-729.27%
Pretax Margin
-552.46%-552.46%-1730.24%-2480.50%-1691.55%-724.43%
Profit Margin
-552.46%-552.46%-1730.24%-2480.50%-1691.55%-724.43%
FCF Margin
-463.11%-463.11%-1107.55%-2848.72%-1482.94%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.437.83----